Home › Pulmonary Arterial Hypertension › Nebraska
Pulmonary Arterial Hypertension clinical trials in Nebraska
3 studies for Pulmonary Arterial Hypertension are looking for participants at sites in Nebraska.
Cities in Nebraska
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
- University of Nebraska Medical Center - 2365, Omaha
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07318597A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- USA028, Omaha
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 16, 2026 · NCT07481981Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- University of Nebraska Medical Center, Omaha
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06274801From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.